Shares of Owens & Minor OMI rose 2.4% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 430.00% over the past year to $1.06, which beat the estimate of $0.97.
Revenue of $2,489,000,000 higher by 37.67% from the same period last year, which beat the estimate of $2,470,000,000.
Outlook
Owens & Minor reaffirmed FY21 adjusted EPS guidance of $3.75-$4.25.
How To Listen To The Conference Call
Date: Aug 03, 2021
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/f3tadffh
Price Action
52-week high: $49.16
Company's 52-week low was at $12.54
Price action over last quarter: Up 42.69%
Company Overview
Owens & Minor distributes consumable medical supplies to a variety of providers. The company operates in two segments that are Global products and Global Solutions. The company offers a portfolio of products and services to healthcare providers and manufacturers in the Global solutions segment. In the Global product segment, the company manufactures and sources medical-surgical products through our production and kitting operations. The majority of the revenue is generated from the Global solutions segment. The company operates in Asia, Europe, Latin America, and the United States, while the majority of revenue comes from the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
